The Role of Cancer-Elicited Inflammatory Biomarkers in Predicting Early Recurrence Within Stage II–III Colorectal Cancer Patients After Curable Resection

BACKGROUND: Smoldering cancer-related inflammation attenuates chemotherapy efficacy and contributes to unsatisfactory outcome for patients of colorectal cancer (CRC). Various inflammation-based biomarkers were reported to predict the survival of the disease, however, it remains unclear which is the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ying, Hou-Qun, Liao, Yu-Cui, Sun, Fan, Peng, Hong-Xin, Cheng, Xue-Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822081/
https://www.ncbi.nlm.nih.gov/pubmed/33500648
http://dx.doi.org/10.2147/JIR.S285129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822081/
https://www.ncbi.nlm.nih.gov/pubmed/33500648
http://dx.doi.org/10.2147/JIR.S285129

Ejemplares similares